-$1.03 Earnings Per Share Expected for Aimmune Therapeutics Inc (NASDAQ:AIMT) This Quarter
Brokerages predict that Aimmune Therapeutics Inc (NASDAQ:AIMT) will report ($1.03) earnings per share (EPS) for the current quarter, according to...
Brokerages predict that Aimmune Therapeutics Inc (NASDAQ:AIMT) will report ($1.03) earnings per share (EPS) for the current quarter, according to...
Only 100 investor and state-owned fossil fuel companies are responsible for around 70 percent of the world’s historical GHG emissions....
It looks like “More Than OK” and Cardi B’s “Okurrr” will have to step aside. Pepsi is launching a new...
Ridiculous decisionAlachua County Judge Kristine Van Vorst was wrong to rule the county airboat noise ordinance "unconstitutional." That ordinance is...
Wood alphabet in word ETF (abbreviation of Exchange Traded Fund) on artificial green grass ... backgroundGettyThe significant underperformance of...
Under the terms of the deal, Beacon will be responsible for drug discovery activities. Arena will focus on developing and...
A new study shows the importance of combining human intelligence with machine learning and AI tools. Combining human...
SSGA FUNDS MANAGEMENT, INC. bought a fresh place in Meredith Corporation (NYSE:MDP). The institutional investor bought 4.2 million shares of...
Here are Drink Ireland’s top 5 trends to watch in 2020: Low and no alcohol beer Sales of low and...
New year, clean slate: That's the thesis for most marijuana stock investors following the drubbing they took in 2019. Last...
© 2025 researchsnappy.com